158 related articles for article (PubMed ID: 23911636)
21. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
Xian W; Zheng H; Wu WJ
Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.
Lv C; Bai Z; Liu Z; Luo P; Zhang J
Int J Clin Exp Pathol; 2015; 8(5):5781-6. PubMed ID: 26191297
[TBL] [Abstract][Full Text] [Related]
23. ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.
Zhang G; Gu C; Zhu Y; Luo L; Dong D; Wan F; Zhang H; Shi G; Sun L; Ye D
Cancer Sci; 2015 Jun; 106(6):687-691. PubMed ID: 25827778
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
25. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
26. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
27. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
28. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ
Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998
[TBL] [Abstract][Full Text] [Related]
29. A common variant at 8q24.21 is associated with renal cell cancer.
Gudmundsson J; Sulem P; Gudbjartsson DF; Masson G; Petursdottir V; Hardarson S; Gudjonsson SA; Johannsdottir H; Helgadottir HT; Stacey SN; Magnusson OT; Helgason H; Panadero A; van der Zanden LF; Aben KK; Vermeulen SH; Oosterwijk E; Kong A; Mayordomo JI; Sverrisdottir A; Jonsson E; Gudbjartsson T; Einarsson GV; Kiemeney LA; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Commun; 2013; 4():2776. PubMed ID: 24220699
[TBL] [Abstract][Full Text] [Related]
30. Association of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysis.
Ou C; Zhao HL; Zhu B; Huang LS; Li PZ; Lao M
J Recept Signal Transduct Res; 2014 Dec; 34(6):463-8. PubMed ID: 24840096
[TBL] [Abstract][Full Text] [Related]
31. Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.
Cai C; Wang LH; Dong Q; Wu ZJ; Li MY; Sun YH
Tissue Antigens; 2013 Sep; 82(3):165-70. PubMed ID: 24032722
[TBL] [Abstract][Full Text] [Related]
32. Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites.
Melkonian SC; Daniel CR; Hildebrandt MA; Tannir NM; Ye Y; Chow WH; Wood CG; Wu X
Am J Epidemiol; 2014 Sep; 180(5):499-507. PubMed ID: 25053674
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
[TBL] [Abstract][Full Text] [Related]
34. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
35. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
Zhu J; Qin C; Yan F; Wang M; Ding Q; Zhang Z; Yin C
Int J Urol; 2010 Aug; 17(8):700-7. PubMed ID: 20529140
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population.
Cao Q; Wang J; Zhang M; Li P; Qian J; Zhang S; Zhang L; Ju X; Wang M; Zhang Z; Li J; Gu M; Zhang W; Qin C; Shao P; Yin C
PLoS One; 2014; 9(10):e109285. PubMed ID: 25329396
[TBL] [Abstract][Full Text] [Related]
37. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
39. Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma.
Korenaga Y; Naito K; Okayama N; Hirata H; Suehiro Y; Hamanaka Y; Matsuyama H; Hinoda Y
Int J Cancer; 2005 Nov; 117(3):431-4. PubMed ID: 15906349
[TBL] [Abstract][Full Text] [Related]
40. The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.
Han SS; Yeager M; Moore LE; Wei MH; Pfeiffer R; Toure O; Purdue MP; Johansson M; Scelo G; Chung CC; Gaborieau V; Zaridze D; Schwartz K; Szeszenia-Dabrowska N; Davis F; Bencko V; Colt JS; Janout V; Matveev V; Foretova L; Mates D; Navratilova M; Boffetta P; Berg CD; Grubb RL; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Albanes D; Weinstein SJ; Virtamo J; Burdett L; Brisuda A; McKay JD; Fraumeni JF; Chatterjee N; Rosenberg PS; Rothman N; Brennan P; Chow WH; Tucker MA; Chanock SJ; Toro JR
Hum Mol Genet; 2012 Mar; 21(5):1190-200. PubMed ID: 22113997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
